Proposed Data Collection Submitted for Public Comment and Recommendations, 26876-26877 [2019-12137]
Download as PDF
<![CDATA[
26876
Federal Register / Vol. 84, No. 111 / Monday, June 10, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Food safety program personnel.
Retail food personnel ..............
NEARS
NEARS
NEARS
NEARS
NEARS
Food Safety Program Training .................................
e-Learning (screenshots) ..........................................
Data Recording (paper form) ....................................
Data reporting and manager’s interview (web entry)
Manager Interview ....................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–12136 Filed 6–7–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–19–0852; Docket No. CDC–2019–
0026]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Prevalence Survey of HealthcareAssociated Infections and Antimicrobial
Use in U.S. Acute Care Hospitals. This
project examines the numbers and types
of Healthcare-Associated Infections and
causative pathogens, types of
antimicrobial drugs (such as antibiotics)
used, and the quality of antimicrobial
prescribing in U.S. acute care hospitals.
DATES: CDC must receive written
comments on or before August 9, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2019–
0026 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:45 Jun 07, 2019
Number of
respondents
Form name
Jkt 247001
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
50
50
300
300
1,200
Number of
responses per
respondent
1
1
1
1
1
Average
burden per
response
(in hours)
2
10
30/60
40/60
20/60
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Prevalence Survey of HealthcareAssociated Infections and Antimicrobial
Use in U.S. Acute Care Hospitals (OMB
Control No. 0920–0852, Exp. 12/31/
2019)—Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated
infections (HAIs) and improving
antimicrobial use (AU) are CDC and
national priorities. An essential step in
reducing the occurrence of HAIs is to
estimate accurately the burden of these
infections in U.S. acute care hospitals
and to describe the types of HAIs and
causative pathogens. Periodic
assessments of the magnitude and types
of HAIs and AU occurring in all patient
populations within acute care hospitals
are needed to inform decisions by
policy makers and hospital infection
control personnel (ICP) regarding
appropriate targets and strategies for
HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four
prevalence surveys (i.e., pilot survey in
2009, limited-scale survey in 2010, and
two full-scale surveys in 2011 and 2015)
in partnership with the CDC’s Emerging
Infections Program (EIP) sites. Findings
from the most recent survey showed a
reduction in the percentage of patients
with healthcare-associated infections
compared with 2011.
Minor adjustments to data collection
instruments since the previous 2016
OMB approval have been made. These
E:\FR\FM\10JNN1.SGM
10JNN1
26877
Federal Register / Vol. 84, No. 111 / Monday, June 10, 2019 / Notices
adjustments were made to enhance
future analyses and utility of the survey
data. These changes are non-substantive
and are not expected to increase the
public reporting burden. An extension
of the prevalence survey’s existing OMB
approval is sought to allow a repeat HAI
and AU Prevalence Survey to be
performed in 2020. A repeat survey will
allow assessment of changes in HAI and
AU prevalence, pathogen distribution,
and quality of antimicrobial prescribing.
These data will also allow CDC and its
partners to continue to monitor HAI and
AU trends, to measure progress in
meeting national targets, and to further
refine prevention strategies.
In the 2020 survey, data collection
will occur within acute care general
hospitals of varying size in each of the
10 EIP sites (i.e., CA, CO, CT, GA, MD,
MN, NM, NY, OR, & TN).
ICP in participating hospitals may
assist EIP site personnel in collecting
represents no change from the 2016
OMB approval.
To assess changes in HAIs and AU
over time, EIP sites will seek
participation from the same hospitals
that participated in prior surveys. These
hospitals were originally selected for
participation using a stratified random
sampling scheme based on the number
of staffed acute care beds (i.e., small:
<150 staffed beds; medium: 151–399
staffed beds; large: >400 staffed beds).
Each site will also have the option to
recruit additional hospitals for a total of
up to 30 in each site. As in previous
surveys, hospital participation will
remain voluntary. Within each
participating hospital, EIP site
personnel will establish patient sample
size targets based on the number of
staffed acute care beds (e.g., up to 75
patients in small hospitals, 75 patients
in medium hospitals, and 100 patients
in large hospitals).
demographic and limited clinical data
from the electronic or paper-based
medical records of a sample of
randomly selected patients on a single
day in 2020. Patients will not be
interviewed, and no direct interaction
with patients will occur. Hospital and
patient-level data will be collected using
unique identification codes. EIP site
personnel will submit hospital and
patient-level data to CDC using a secure
data management system.
Based on experiences from previous
surveys, the time required to complete
the Healthcare Facility Assessment
Form (HFA) and Patient Information
Form (PIF) is estimated to be 45 and 17
minutes, respectively. To conduct the
full-scale survey in a three-year
approval period, 100 hospital
respondents will complete the HFA one
time and the PIF on average 63 times
per year. The total estimated annualized
public burden is 1,860 hours, which
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Hospital
Staff
Preventionist).
(i.e.,
Infection
Total ...........................................
1
45/60
75
Patient Information Form .................
100
63
17/60
1,785
...........................................................
........................
........................
........................
1,860
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–855R]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
khammond on DSKBBV9HB2PROD with NOTICES
Total burden
(in hours)
100
[FR Doc. 2019–12137 Filed 6–7–19; 8:45 am]
Jkt 247001
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments on the collection(s) of
information must be received by the
OMB desk officer by July 10, 2019.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
DATES:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
SUMMARY:
16:45 Jun 07, 2019
Average
burden per
response
(in hours)
Healthcare Facility Assessment .......
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Number of
responses per
respondent
Number of
respondents
Form name
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 84, Number 111 (Monday, June 10, 2019)]
[Notices]
[Pages 26876-26877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12137]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-19-0852; Docket No. CDC-2019-0026]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Prevalence Survey of Healthcare-
Associated Infections and Antimicrobial Use in U.S. Acute Care
Hospitals. This project examines the numbers and types of Healthcare-
Associated Infections and causative pathogens, types of antimicrobial
drugs (such as antibiotics) used, and the quality of antimicrobial
prescribing in U.S. acute care hospitals.
DATES: CDC must receive written comments on or before August 9, 2019.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0026 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Exp. 12/31/2019)--Extension--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and improving
antimicrobial use (AU) are CDC and national priorities. An essential
step in reducing the occurrence of HAIs is to estimate accurately the
burden of these infections in U.S. acute care hospitals and to describe
the types of HAIs and causative pathogens. Periodic assessments of the
magnitude and types of HAIs and AU occurring in all patient populations
within acute care hospitals are needed to inform decisions by policy
makers and hospital infection control personnel (ICP) regarding
appropriate targets and strategies for HAI prevention and antimicrobial
stewardship.
Since 2009, CDC has conducted four prevalence surveys (i.e., pilot
survey in 2009, limited-scale survey in 2010, and two full-scale
surveys in 2011 and 2015) in partnership with the CDC's Emerging
Infections Program (EIP) sites. Findings from the most recent survey
showed a reduction in the percentage of patients with healthcare-
associated infections compared with 2011.
Minor adjustments to data collection instruments since the previous
2016 OMB approval have been made. These
[[Page 26877]]
adjustments were made to enhance future analyses and utility of the
survey data. These changes are non-substantive and are not expected to
increase the public reporting burden. An extension of the prevalence
survey's existing OMB approval is sought to allow a repeat HAI and AU
Prevalence Survey to be performed in 2020. A repeat survey will allow
assessment of changes in HAI and AU prevalence, pathogen distribution,
and quality of antimicrobial prescribing. These data will also allow
CDC and its partners to continue to monitor HAI and AU trends, to
measure progress in meeting national targets, and to further refine
prevention strategies.
In the 2020 survey, data collection will occur within acute care
general hospitals of varying size in each of the 10 EIP sites (i.e.,
CA, CO, CT, GA, MD, MN, NM, NY, OR, & TN).
ICP in participating hospitals may assist EIP site personnel in
collecting demographic and limited clinical data from the electronic or
paper-based medical records of a sample of randomly selected patients
on a single day in 2020. Patients will not be interviewed, and no
direct interaction with patients will occur. Hospital and patient-level
data will be collected using unique identification codes. EIP site
personnel will submit hospital and patient-level data to CDC using a
secure data management system.
Based on experiences from previous surveys, the time required to
complete the Healthcare Facility Assessment Form (HFA) and Patient
Information Form (PIF) is estimated to be 45 and 17 minutes,
respectively. To conduct the full-scale survey in a three-year approval
period, 100 hospital respondents will complete the HFA one time and the
PIF on average 63 times per year. The total estimated annualized public
burden is 1,860 hours, which represents no change from the 2016 OMB
approval.
To assess changes in HAIs and AU over time, EIP sites will seek
participation from the same hospitals that participated in prior
surveys. These hospitals were originally selected for participation
using a stratified random sampling scheme based on the number of
staffed acute care beds (i.e., small: <150 staffed beds; medium: 151-
399 staffed beds; large: >400 staffed beds). Each site will also have
the option to recruit additional hospitals for a total of up to 30 in
each site. As in previous surveys, hospital participation will remain
voluntary. Within each participating hospital, EIP site personnel will
establish patient sample size targets based on the number of staffed
acute care beds (e.g., up to 75 patients in small hospitals, 75
patients in medium hospitals, and 100 patients in large hospitals).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Staff (i.e., Healthcare 100 1 45/60 75
Infection Preventionist). Facility
Assessment.
Patient 100 63 17/60 1,785
Information
Form.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,860
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-12137 Filed 6-7-19; 8:45 am]
BILLING CODE 4163-18-P
